Anthony Fauci said US was leaving a "full-blown" pandemic behind, while drugmaker Pfizer forecast more than $50 billion in 2022 sales

Shares of WuXi Biologics plunge 25% after Commerce Dept adds 33 Chinese entities to its 'unverified list', which requires exporters to go through more procedures before shipping goods

The company said governments and private customers can instantly verify the provenance and authenticity of vaccines and other drugs

The action follows November's regulatory guidelines to stamp out monopolies in active pharmaceutical ingredients

  The US has banned imports from YTY Industry Holdings, a Malaysian manufacturer of personal protective equipment (PPE), over suspected...

Canada detected a case of bovine spongiform encephalopathy in December 2021 on an Alberta farm, the country's first known BSE case in six years

Takeshi Kasai is accused of presiding over a "toxic atmosphere" at the regional office with a culture of "systemic bullying and ridiculing"

JV is devoted to the development and production of biosimilars, compounds close in structure to a biologic, which is made from proteins

China will have to turn to dividends from its elderly as its population declines, one expert said, while Hong Kong's stock exchange sees biotech applications as a way to manage an ageing society

Federal officials found Xiang Haitao in possession of copies of a proprietary predictive algorithm as he was waiting to board a flight to China 

The Nasdaq-listed biotechnology firm approached Samsung to sell its shares, which could be valued at more than 50 trillion won ($42 billion)

The fund follows an ethical mandate set by parliament and is not allowed to invest in companies that produce nuclear weapons and tobacco, among other things